Thomas Salzmann

Plus aucun poste en cours

Health Technology

Finance

Profil

Dr. Salzmann sits on the Board and SAB of Satori Pharmaceuticals, a PureTech portfolio company.
Previously he was Executive Vice President, Merck Research Labs.
Dr. Salzmann's career at Merck spanned nearly 30 years in which he has also held positions including EVP Worldwide Preclinical Development, Global Operations, and Project Management and SVP Basic Research and Chemistry.
He is also a member of the MRL Executive Committee.

Anciens postes connus de Thomas Salzmann

Sociétés	Poste	Fin
Puretech Health LLC Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements.	Private Equity Investor	30/07/2008
Satori Pharmaceuticals, Inc. Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease	Directeur/Membre du Conseil	-
MERCK & CO., INC.	Corporate Officer/Principal	-

Voir l'expérience en détail de Thomas Salzmann

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées